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Abstract
Links between synaptic plasticity in the lateral amygdala (LA) and Pavlovian fear learning are well established.
Neuropeptides including gastrin-releasing peptide (GRP) can modulate LA function. GRP increases inhibition in the LA and
mice lacking the GRP receptor (GRPR KO) show more pronounced and persistent fear after single-trial associative learning.
Here, we confirmed these initial findings and examined whether they extrapolate to more aspects of amygdala physiology
and to other forms of aversive associative learning. GRP application in brain slices from wildtype but not GRPR KO mice
increased spontaneous inhibitory activity in LA pyramidal neurons. In amygdala slices from GRPR KO mice, GRP did not
increase inhibitory activity. In comparison to wildtype, short- but not long-term plasticity was increased in the cortico-lateral
amygdala (LA) pathway of GRPR KO amygdala slices, whereas no changes were detected in the thalamo-LA pathway. In
addition, GRPR KO mice showed enhanced fear evoked by single-trial conditioning and reduced spontaneous firing of
neurons in the central nucleus of the amygdala (CeA). Altogether, these results are consistent with a potentially important
modulatory role of GRP/GRPR signaling in the amygdala. However, administration of GRP or the GRPR antagonist (D-Phe
6,
Leu-NHEt
13, des-Met
14)-Bombesin (6–14) did not affect amygdala LTP in brain slices, nor did they affect the expression of
conditioned fear following intra-amygdala administration. GRPR KO mice also failed to show differences in fear expression
and extinction after multiple-trial fear conditioning, and there were no differences in conditioned taste aversion or gustatory
neophobia. Collectively, our data indicate that GRP/GRPR signaling modulates amygdala physiology in a paradigm-specific
fashion that likely is insufficient to generate therapeutic effects across amygdala-dependent disorders.
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Introduction
Pavlovian fear conditioning models associative fear learning, a
process that is thought to be involved in the etiology of human
anxiety [1–3]. The amygdala is a key neuroanatomical and
physiological substrate for fear learning [4–6]. This structure
relays information to autonomic and somatomotor centers that
mediate specific fear responses [4,7]. Fear conditioning induces
long term potentiation (LTP)-like changes in thalamo- and cortico-
amygdala synaptic transmission [8,9] and both fear conditioning-
and LTP-induced plasticity share common mechanisms of
induction and expression (for review see [10,11]).
Amygdala LTP and conditioned fear are under tight control of
local inhibitory GABAergic interneurons. A wealth of clinical
imaging data implicates hyperfunctioning of the amygdala in
anxiety disorders such as social anxiety, phobias and post-
traumatic stress disorder [12,13] and there appear to be learning
components in the etiology of these diseases [14,15]. Neuropep-
tides may modulate anxiety- and stress-related behavioral effects
through their actions on distinct subpopulations of neurons located
in the lateral and/or central lateral (CeL) and central medial
(CeM) amygdala nuclei. For example, the neuropeptide oxytocin
which has strong anxiolytic effects, excites a subpopulation of
CeM-projecting inhibitory neurons in the CeL [16]. Neuromod-
ulatory projections that limit amygdala excitability likely serve to
prevent the formation of exaggerated conditioned responses and
pathological states such as anxiety (for review see [17]). Therefore,
pharmacological agents that alter specific inhibitory activities in
the amygdala or otherwise limit amygdala excitability may offer
novel therapeutic strategies for the treatment of mood and anxiety
disorders associated with amygdala hyperexcitability.
Gastrin-releasing peptide (GRP) is produced in the amygdala
and excites local interneurons via the gastrin-releasing peptide
receptor (GRPR). Mice deficient in GRPR show greater and more
persistent fear memory after single-trial associative learning and it
has been proposed that agonists may be developed as therapies for
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34963fear-related disorders [18]. GRPR also has a role in the regulation
of immune function [19], itch [20] and is implicated in the
pathogenesis of human cancers [21] which may limit the utility of
activators as therapies.
To gain a better understanding of the specific versus more
general role of GRP/GRPR signaling in the fear circuit, we
assessed the role of GRP and its receptor in the amygdala, in single
versus multiple-trial fear conditioning and in other amygdala-
dependent paradigms.
Results
GRPR expression in the amygdala
To determine which cell types in the mouse amygdala express
GRPR we used combined in situ detection of GRPR mRNA and
immunofluorescent detection of eGFP in GAD67-eGFP mouse
brain sections. GRPR mRNA was mostly co-localized with eGFP
in a subset of GAD67-eGFP neurons (Fig. 1 C, D). In the LA
and basolateral amygdala (BLA) GRPR mRNA was expressed
primarily in GAD67-eGFP positive GABAergic neurons (Fig. 1A,
B). GABAergic neurons in the intercalated cell masses lacked
GRPR mRNA. In the central amygdala (CeA), the lateral
nucleus (CeL) contained a dispersed set of GAD67-eGFP neurons
expressing GRPR but the medial nucleus (CeM) was largely
devoid of such cells.
GRP increases inhibitory activity in lateral amygdala
principal neurons. Administration of GRP to amygdala slices
in vitro enhanced the number of spontaneous inhibitory currents
recorded from principal neurons in the LA. Addition of 200 nM
GRP increased spontaneous IPSCs in slices from wild-type (WT,
paired t-test; p=0.046, n=6) but not GRPR knock-out mice
(GRPR KO, paired t-test; p=0.42, n=4; Fig. 1E, F). The control
IPSC frequencies were not different between the genotypes (WT
4.360.9 s
21, n=6; KO 8.362.8 s
21 n=4, p=0.14). Picrotoxin
blocked all inward currents confirming that these were mediated
by activation of fast GABAA receptors (Fig. 1E). Activation
of GRPR by GRP therefore increased spontaneous inhibitory
activity in LA pyramidal neurons in agreement with earlier
findings [18]. Since the LA is thought to be the principle site
where conditioned-stimulus (CS)-unconditioned stimulus (US)
associations are formed, GRP/GRPR signaling in the LA is
likely at least part of the mechanism via which this cascade
influences the acquisition and/or expression of associative fear
memory.
Reduction of single-unit firing frequencies in CeM
neurons in vivo
The CeA is the principle output structure of the amygdaloid
complex. Output neurons that mediate endocrine, autonomic and
motor aspects of fear responses are mainly located in CeM, which
in turn is under inhibitory control from the CeL. Fear conditioning
leads to increased activity of LA neurons, which can project to
CeL [22] and to decreased basal firing of CeM neurons [23]. Since
GRPR expressing neurons are located both in LA and CeL, we
tested whether GRPR ablation changed baseline activity in CeM.
Single unit recordings were conducted from the CeM of
anaesthetized mice (example of most rostral and ventral recording
site Fig. 1G). The results show that the majority of neurons in
CeM fired at frequencies below 3 Hz. A total of 141 single units
were recorded from 12 WT mice and 136 single units were
recorded from 12 GRPR KO mice. The mean firing rate of CeM
neurons was 1.3260.12 s
21 in the WT and 0.9160.09 s
21 in the
KO mice. Kolmogorov-Smirnov analysis indicated that the
distribution of firing frequencies of CeM neurons were different
in the WT and GRPR KO mice (p,0.001; Fig. 1H). These
findings show that GRPR ablation decreases basal firing rates of
CeM neurons.
Enhanced fear responses in GRPR KO mice following
single-trial conditioning
To evaluate whether the decreased firing rates of CeM neurons
in GRPR KO mice translate to changes in amygdala-dependent
behavior, we tested GRPR KO mice in a fear conditioning
paradigm. Using a one trial fear conditioning protocol, we found
that during the single pairing of a tone with a foot shock, the levels
of freezing were not significantly different in GRPR-deficient mice
and WT littermates (t-test: p=0.33) (data not shown). In addition,
the reactivity to the aversive stimulus (electric foot shock) was
similar in mice of both genotypes (movement velocity: mean 6
sem in cm/s: WT 5263, KO 5462, t-test p=0.52). When the
mice were re-exposed to the conditioning context 24 h after the
training, both mutant and WT animals exhibited 42% contextual
freezing during the 3 min retention test (Fig. 2A). In the re-test
performed 2 weeks later, this response was not modified and no
difference in freezing due to genotype was observed (two-way
ANOVA: Genotype: F(1,21)=0.18; p=0.67; Time: F(1,21)=0.83;
p=0.37; Genotype6Time: F(1,21)=0.55; p=0.46). Three hours
after each contextual retention test, the mice were placed in a
novel environment and submitted to a retention test for the cue
(Fig. 2B). When the animals were tested 24 h after conditioning,
all displayed an increase in freezing during the tone presentation
(Cue) as compared to the freezing prior to the tone (Pre-Cue) (two-
way ANOVA: Genotype: F(1,21)=2.50; p=0.13; Test condition:
F(1,21)=24.99; p,0.001; Genotype6Test condition: F(1,21)=2.65;
p=0.12; post-hoc paired t-tests WT: p=0.023, GRPR KO:
p=0.002). However, as shown in Fig. 2B GRPR KO mice froze
significantly more than the WT mice (ANOVA: Genotype:
F(1,21)=5.27, p=0.03), demonstrating that 24 h after single trial
fear-conditioning, the absence of GRPR enhanced the expression
of learned fear as reported by Shumyatsky et al. [18]. When the
mice were retested 2 weeks after the conditioning, GRPR KO as
compared to WT mice showed significantly larger freezing
responses both during the pre-cue period (ANOVA: Genotype:
F(1,21)=7.81, p=0.01) and during the cue presentation (ANOVA:
Genotype: F(1,21)=4.57, p=0.04; Fig. 2B). It is important to note,
however, that freezing did not increase when the cue was
presented but remained the same as in the pre-cue period (two-
way ANOVA: Genotype: F(1,21)=7.59, p=0.01 Trial condition:
F(1,21)=0.04; p=0.84; Genotype6trial condition: F(1,21)=0.88,
p=0.36). Thus, whereas 24 h after single-trial conditioning the
GRPR KO mice showed an enhanced fear response to the
conditioned cue, 2 weeks later they showed a generalized
enhanced freezing response that was unspecific to the cue.
Lack of GRPR does not affect multiple-trial fear learning
and extinction
The previous experiment used a simple and fairly weak single-
trial protocol to induce associative fear learning. We went on to
examine whether the learning induced by multiple CS-US pairings
would also be modified by the lack of GRPR. When the CS and
US were paired 6 times, freezing during the tone increased with
the repeated tone-shock pairings (Fig. 2C, inset, two-way
ANOVA: Trial number: F(5,225)=24.09; p,0.001). There was,
however, no significant difference between WT and GRPR KO
mice during the conditioning (Genotype: F(1,45)=0.54; p=0.47;
Genotype6Trial number: F(5,225)=0.66; p=0.65). The reactivity
to the foot shock (velocity) was similar in both genotypes (WT:
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PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e34963Figure 1. The gastrin-releasing peptide receptor is expressed in interneurons in the lateral amygdala and affects amygdala
physiology. A) In situ hybridization of the GRPR in the amygdala. B) Binary version of A) that more clearly distinguishes the ISH signal (white dots),
mainly in the lateral (LA) and basolateral (BLA) with only very few labeled cells in the central lateral (CeL) and central medial (CeM) nuclei. C) Higher
power image showing ISH signal in neurons that were D) co-immunolabeled for eGFP being expressed under control of the GAD67 promoter. E)
Sample recordings of spontaneous inhibitory postsynaptic currents recorded from LA pyramidal neurons in control conditions, in the presence of
GRP and after addition of picrotoxin in slices made from WT and GRPR KO mice. The patch pipette contained high Cl
2 therefore IPSCs were inward at
the holding potential of 270 mV. CNQX (20 mM) was present to block fast excitatory activity. Picrotoxin (100 mM) blocked all the inward currents
confirming their inhibitory nature. F) Quantification of the results from 6 slices from WT and 4 slices from GRPR KO mice. G) Typical example of the
most rostral and ventral in vivo recording position in the central medial nucleus of the amygdala. H) Cumulative frequency plot of CeM single unit
activity from 12 WT and 12 GRPR KO mice. Inset shows a sample record.
doi:10.1371/journal.pone.0034963.g001
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F(1,45)=0.07; NS). Twenty-four hours after conditioning, the
freezing response induced by the cue was evaluated in all mice
prior to the extinction procedure (Fig. 2C). Although freezing
during the pre-cue period was slightly higher in GRPR KO mice,
this was not significantly different (ANOVA: Genotype:
F(1,45)=1.84, p=0.18). Likewise, there was no significant differ-
ence between WT and GRPR KO mice in the expression of cue-
induced freezing (respectively, 54 and 53% of cue-induced
freezing) (ANOVA Genotype: F(1,45)=0.11; p=0.74). After
completing the 3 days of extinction training, mice of both
genotypes displayed significantly less freezing in response to cue
presentation (p,0.001) than did their respective ‘No Extinction’
group during the final retention test on day 5 (Fig. 2D). A two-way
ANOVA indicated that there was a significant effect of the
extinction procedure, but no effect of genotype and no interaction
between both factors (Extinction group: F(1,43)=25.06; p,0.001;
Genotype: F(1,43)=0.96; p=0.33; Extinction group6Genotype:
F(1,43)=0.004; p=0.95). Thus, when a stronger multiple CS-US
pairing fear-conditioning protocol is used, there is no longer
a significant effect of GRPR deletion on the conditioned fear
response.
Absence of GRPR alters short but not long-term plasticity
in amygdala slices
We examined whether synaptic plasticity was altered in
amygdala slices of GRPR KO mice. Field potentials (fEPSPs) in
the LA, evoked by stimulation of thalamic inputs, were
significantly potentiated following 5 trains of 100 Hz/1 s stimu-
lation in both GRPR KO and WT littermates (Fig. 3A, B). In the
first 2 min following the tetanic stimulation, the amount of post-
tetanic potentiation of thalamo-LA synapses was not significantly
different between acute slices from WT and GRPR KO mice (t-
test, p=0.13, Fig. 3A, B). There was also no significant difference
in the amount of long-term potentiation (LTP), measured 30–
40 min post-tetanus, between slices from GRPR KO and WT
littermates (t-test, p=0.85; Fig. 3A, B). Similarly, there was no
difference in cortico-LA LTP between GRPR KO and WT mice
(t-test, p=0.35; Fig. 3C, D). However, PTP of the cortico-LA
fEPSP slope was larger in amygdala slices from GRPR KO mice
(t-test, p=0.05; Fig. 3C, D). These findings suggest that the
absence of GRPR in the LA mainly affected short-lasting synaptic
plasticity.
We next tested whether pairing of postsynaptic depolarization of
whole-cell patch-clamped pyramidal neurons in the LA with
presynaptic stimulation of the cortical inputs at 2 Hz, would better
reveal differences in cortico-LA plasticity in GRPR KO mice. As
LTP is highly susceptible to the washout of postsynaptic second
messengers, we applied the pairing paradigm within 10 min of
gaining whole-cell access and restricted our comparisons to only
those experiments in which there was significant LTP. There was
no significant difference in the amount of LTP in GRPR KO and
WT mice (t-test, p=0.44; Fig. 3E, F). The amount of PTP again
tended to be higher in the recordings from the GRPR KO mice (t-
Figure 2. Expression of conditioned fear is altered in GRPR KO mice after single-pairing but not multiple-pairing conditioning. A,B)
Fear conditioning was induced by a single CS-US (tone-shock) pairing in context 1. 24 h and 2 weeks later the freezing response in the same context
was tested A and response to the cue alone was tested in a new context B (WT n=12, GRPR KO n=11). C,D) To test for extinction of conditioned fear
GRPR KO (n=12) and WT mice (n=11) were subjected to multiple CS-US (tone-shock) pairing in context 1. Freezing levels during acquisition are
shown in the inset in C. C) At the start of extinction training, baseline (pre-cue) and cue-related freezing responses were tested in a new context. D)
At the end of 4 days of extinction training, the freezing response to the cue was tested in mice that were handled but not given the training (no
Extinction; n=12) and mice subjected to extinction training (Extinction; 10 presentations of CS alone each day).
doi:10.1371/journal.pone.0034963.g002
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GRPR failed to affect thalamic-LA LTP and cortico-LA LTP,
irrespective of its mode of induction using either trains of tetanic
stimuli or pairing of postsynaptic depolarization with presynaptic
stimulation.
GRP and GRPR antagonists do not affect cortico-LA LTP
in amygdala slices
In amygdala slices of WT mice, the GRPR antagonist (D-Phe
6,
Leu-NHEt
13, des-Met
14)-Bombesin (6–14) (1 mM) had no effect on
LTP of cortico-LA fEPSPs (t-test, p=0.59; Fig. 3G, H). Blocking
of GRPRs would be expected to reduce the activation of
interneurons during the induction of LTP. To ensure that our
experimental conditions permitted detection of an enhancement of
LTP by such a mechanism, we added a low concentration of
picrotoxin (5 mM) to partially block inhibition. Reducing inhibi-
tion significantly increased the amount of LTP induced by tetanic
stimulation (t-test vs control, p=0.001; Fig. 3G, H) suggesting that
our experimental conditions were not confounded by a ceiling
effect that would have prevented detection of GRPR antagonist
effects on LTP. Application of 200 nM GRP also did not
significantly reduce cortico-LA LTP (Fig. 3I, J; t-test, p=0.22).
Thus, consistent with the multiple-trial conditioning protocols and
the effects of genetic deletion of GRPR, we found no significant
effect of GRP or the antagonist on cortico-LA synaptic plasticity.
Intra-amygdala administration of GRP or a GRPR
antagonist do not affect conditioned freezing
Genetic deletion of important receptor systems may induce
compensatory mechanisms. Therefore, we tested whether acute
bilateral intra-amygdala administration of GRP or the GRPR
antagonist (D-Phe
6, Leu-NHEt
13, des-Met
14)-Bombesin (6–14)
affected the expression of learned fear in C57BL/6 mice. Of the
75 animals used for the experiments 17 animals (22%) had to be
excluded from the final analysis after inspection of the injection
sites because of either misplaced injections or lesions of the
amygdala (Fig. 4C shows the injection sites). All the mice used
in this experiment were first conditioned with the identical
multiple-trial fear conditioning protocol as described above when
comparing GRPR WT and KO mice. During conditioning,
freezing increased significantly (ANOVA, Trial type: F’s.11.05,
p’s,0.001) but no differences between the groups were observed
(ANOVA, Group and interaction Group6Trial type: F’s,1.23,
p.0.28; data not shown). One day after conditioning, GRP or the
GRPR antagonist were injected 10 min prior to the retention test
for either context-induced freezing or, in a separate group of
animals, for cue-induced freezing. Intra-amygdala infusions of
GRP or (D-Phe
6, Leu-NHEt
13, des-Met
14)-Bombesin (6–14) had
no statistically significant effect on context-induced freezing
(Fig. 4A, ANOVA Treatment: F(2,32)=0.49, p=0.62). Likewise,
infusion of GRP 10 min before the retention test had also
no significant effect on cue-induced freezing (Treatment:
F(1,21)=0.12, p=0.74, Fig. 4B). As effects of intra-amygdala
GRP and a GRPR antagonist were shown to be restricted to
context-induced freezing in rats, we decided to spare animals and
not to test the antagonist effects on cued fear [24,25]. Altogether,
intra-amygdala administration of GRP or a GRPR antagonist
showed no significant effects on fear responses after multiple-trial
fear conditioning.
Lack of GRPR does not affect conditioned taste aversion
(CTA)
To test whether other forms of aversive memory might be
sensitive to GRP/GRPR signaling, we tested whether GRPR
ablation influenced conditioned taste aversion (CTA) and/or
gustatory neophobia. On the day of conditioning, mice of both
genotypes readily consumed saccharin solution and were then
injected with either LiCl or NaCl solution (saccharin solution
intake; WT: 1.7060.09 ml LiCl injected group; 1.8160.06 ml
NaCl injected group; GRPR KO: 1.9660.08 ml LiCl injected
group; 1.8160.07 ml NaCl injected group; F(1,42)=2.73; p.0.1).
Figure 3. Long-term potentiation in the LA is not changed in GRPR KO mice or by agonist/antagonist application. A) Thalamic
afferents were stimulated to evoke field excitatory postsynaptic potentials (fEPSPs) in the LA. Inset shows sample averaged traces (10 sweeps) from
the 10 min baseline period (black) immediately before applying the tetanus (56100 Hz/1 s trains, 20 s inter-train interval) and 40 min after the
tetanus (grey). B) Mean 6 s.e.m. of the change in fEPSP slope in the first 2 minutes after the tetanus (PTP) and 30–40 min after the tetanus. C,D)A si n
A,B except that cortical afferents were stimulated to evoke fEPSPs in the LA. E,F) Cortical afferents were stimulated at 30 s intervals to evoke EPSCs
recorded from LA pyramidal neurons at 270 mV with the whole-cell voltage clamp technique. After a 10 min baseline 80 stimuli at 2 Hz were paired
with depolarization to 30 mV. G,H) Long-term potentiation of cortico-LA fEPSPs induced by 56100 Hz/1 s trains was not affected by bath application
of 1 mM (D-Phe
6,Leu-NHEt
13,des-Met
14)-Bombesin(6–14). Reducing inhibitory inputs by addition of 5 mM picrotoxin increased LTP. I,J)1mM GRP also
did not significantly affect cortico-LA LTP.
doi:10.1371/journal.pone.0034963.g003
Figure 4. Exogenous GRP or GRPR antagonist did not affect expression of conditioned fear. A) 600 ng GRP or 3000 ng GRPR antagonist
(D-Phe
6,Leu-NHEt
13,des-Met
14)-Bombesin(6–14) was infused into the amygdala of C57BL/6 mice, that were conditioned with 6 CS-US pairings as in
Fig. 2C, 10 min prior to testing freezing in the conditioning context 24 h later. B) Effect of intra-amygdala infusion of 600 ng GRP 10 min prior to
testing freezing in response to the CS. C) Location of the bilateral injection sites determined from post-hoc histological analysis.
doi:10.1371/journal.pone.0034963.g004
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were given only water to drink prior to injecting NaCl. Both
conditioned WT and GRPR KO mice (LiCl-treated animals)
developed similar, robust levels of CTA to saccharin and
preferentially drank water on day 1 after the conditioning
(Fig. 5A). When compared to the saccharin-exposed animals that
received NaCl injections, two factor ANOVA (factors: genotype,
treatment) indicated that there was no significant difference in
aversion index (AI) on day 1 between WT and GRPR KO
mice (F(1,42)=0.95; p.0.3), no genotype6treatment interaction
(F(1,42)=0.31; p.0.5), but a highly significant difference in AI
between the groups that received LiCl versus NaCl injections
(F(1,42)=739.6; p,0.001, Fig. 5A). When compared with the
group that never received saccharin, there was no difference in AI
on day 1 between WT and GRPR KO mice (F(1,43)=0.10;
p.0.7), no genotype6treatment interaction (F(1,43)=1.46; p.0.2),
but a highly significant effect of LiCl (F(1,43)=103.9; p,0.001). In
summary, both WT and GRPR KO mice developed an equally
robust CTA to saccharin when its first exposure was paired with
LiCl-induced sickness. When offered the choice of drinking
saccharin or water on each of the next 14 days, all LiCl-treated
animals showed extinction of the CTA irrespective of genotype
(Fig. 5A) and repeated-factor ANOVA (factors: genotype, day as
repeated factor) revealed no significant difference between WT
and GRPR KO mice (F(1,22)=2.12; p=0.16), no significant
genotype6day interaction (F(13,286)=0.65; p=0.61) but a highly
significant effect of day (F(13,286)=53.6; p,0.001, Fig. 5A).
Altogether, these findings suggest that GRPR signaling does not
play a significant role in the acquisition, expression and extinction
of CTA.
The expression of neophobia to novel tastes in rodents is highly
dependent on amygdala function and is intricately involved in the
expression of CTA. We therefore also assessed whether WT and
GRPR KO animals either expressed different levels of neophobia
or showed differences in its attenuation. On day 1, animals naive
to saccharin had a significantly higher AI than animals that were
given saccharin the previous day (NaCl group). This behavior
typically reflects mice exhibiting neophobia to saccharin on first
exposure (F(1,41)=27.1; p,0.001, Fig. 5B). There was however, no
difference in AI between WT and GRPR KO mice (F(1,41)=0.36;
p.0.5) and no conditioning group6genotype interaction
(F(1,41)=0.69; p.0.4). Attenuation of neophobia was subsequently
achieved by a repeated several-day exposure of the mice to
saccharin (without LiCl-induced malaise). As a result, all mice
independent of genotype, drank almost exclusively saccharin when
given the choice (Fig. 5B). These findings suggest that GRPR KO
mice and their WT littermates show similar levels of innate fear
and its attenuation as measured by gustatory neophobia.
Discussion
Our data showed that GRP/GRPR signaling in the amygdala
increased inhibitory activity in the LA, modulated single-unit firing
frequency in the CeM nucleus and altered short- but not long-term
synaptic plasticity in the LA. These physiological changes in the
amygdala might explain enhanced fear responses in GRPR KO
mice following single-trial conditioning but they are insufficient to
significantly affect multiple-trial fear learning and extinction or
other forms of associative aversive memory such as CTA. We saw
that short-term plasticity in the cortico-LA pathway was enhanced
in GRPR KO mice, suggesting that GRP/GRPR signaling limits
the activation of this pathway in WT mice. We confirmed that
GRPR is localized in a subset of GABAergic interneurons in the
amygdala and that GRP application increased spontaneous IPSC
frequency in LA pyramidal neurons suggesting that GRP indeed
stimulates GABAergic interneurons in the LA [18,26]. The LA is
thought to be the principle site where CS-US associations are
formed (for review see [22]). Therefore, GRP/GRPR signaling in
the LA likely accounts for at least part of the mechanism via which
the neuropeptide GRP influences the acquisition and/or expres-
sion of associative fear memory for weak single-trial conditioned
stimuli. Importantly, genetic and pharmacological manipulation of
GRP/GRPR signaling did not affect experimentally evoked
cortico- and thalamic-LA LTP, nor did it affect the formation
and expression of strong multiple CS-US pairing-evoked condi-
tioned fear memories. The evidence that inhibition in the
amygdala plays an important role in fear learning and extinction,
is overwhelming [23,27]. Interestingly, our results suggest that the
activity of subclasses of inhibitory neurons other than or in
addition to those sensitive to GRP would have to be targeted to
interfere with strongly conditioned responses [28–30]. Further-
more, modulation via GRP/GRPR signaling is not apparent for
Figure 5. GRPR KO animals showed no differences in conditioned tast aversion (CTA) or neophobia. A) CTA was evoked by pairing a
novel taste, saccharin, with a LiCl injection to induce illness the day before testing (LiCl; n=12 mice per group). Control animals were offered the
novel taste saccharin but injected with NaCl (NaCl groups; n=11 mice per group) or given only water to drink and injected with NaCl the previous
day (saccharin naive groups; n=12 mice per group). B) Attenuation of neophobia and neophobia were assessed by comparing the aversion to
saccharin on first exposure (saccharin naive) with the aversion shown by mice that were exposed to saccharin the previous day (NaCl). On successive
days the neophobia was attenuated by repeatedly being given the chance to drink saccharin flavored water.
doi:10.1371/journal.pone.0034963.g005
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independent of motor activity and considered a rather mild form
of aversive learning [31,32]. Finally, GRPR ablation also did not
affect gustatory neophobia, a kind of innate fear against novel
tastes that is highly amygdala-dependent and required for CTA
[33].
We observed that GRPR KO mice showed enhanced freezing
response to cue 24 h after single-trial fear conditioning, but we did
not confirm the effects on contextual freezing or the persistence of
fear memory reported by Shumyatsky et al., [18]. Similar CS-US
parameters produced lower freezing responses in our hands
(,60% vs about 80%) and this might provide one explanation why
fear memory in GRPR KO mice was less persistent under our
experimental conditions. The lack of effect on LTP in our study is
also in contrast to the earlier finding that LTP is enhanced in
amygdala slices from mice lacking GRPR [18]. We attempted to
precisely replicate the experimental design of the earlier report.
Non-identical experimental housing conditions and/or breeding
history might have contributed to these differences [34]. Mice
lacking for example the closely related bombesin receptor 3 show
alterations in weight gain, stereotypic movement and social
responses when housed singly vs in groups [35]. It has been
reported that chronic corticosterone exposure potentiates stressor-
elicited GRP release in the CeA. Therefore, GRP/GRPR
signaling might be particularly sensitive to stress levels [36]. It is
also noteworthy that others are unable to exactly replicate the
originally reported phenotype of enhanced fear to both context
and cue in the GRPR KO mice [37].
To try and rule out confounds such as compensatory changes in
GRPR KO mice we examined in vivo and in vitro the effects of
exogenous GRP and a GRPR antagonist. Numerous studies have
highlighted the role of amygdala LTP as a physiological correlate
of fear learning (reviewed in [38,39]. In the present study, LA LTP
was unchanged after application of either exogenous GRP or a
GRPR antagonist. Furthermore, when injected into the amygdala
in vivo, these compounds also failed to modify the expression of
context and cue conditioned fear after multiple trial conditioning.
Earlier reports documented that GRP injected into the rat CeA,
prelimbic and infralimbic cortices reduced conditioned freezing
[40]. Central (i.c.v) administration of GRP has also been reported
to reduce fear-potentiated startle and conditioned freezing
responses. The GRPR antagonist RC-3095 was shown to block
the reduction of context and cued fear normally observed over
time [41] also see [42]. On the contrary, infusion of either GRP or
the GRPR antagonist RC-3095 into the BLA has anxiolytic-like
effects on the expression of conditioned freezing [25]. Roesler et
al., [43] showed that systemic or intra-amygdala (BLA) injection
of RC-3095 impaired aversive memory consolidation without
altering object recognition memory. Thus, anxiolytic-like effects
have been reported for both activation and blockade of GRPR-
mediated signaling suggesting that it is exceedingly difficult to
predict the overall effect of systemic brain-penetrating GRPR
agonists/antagonists. Indeed, systemic application of GRP or its
amphibian homologue bombesin enhances memory retention
following aversive training protocols. This effect is attenuated by
vagotomy and transient inactivation of the NTS or amygdala
suggesting that a systemic agonist may have opposing effects at the
periphery and in the CNS and may enhance rather than decrease
fear [44,45].
In conclusion, our results collectively with earlier reports
indicate that GRP/GRPR signaling plays a subtle and complex
role in amygdala physiology. Increasing inhibitory activity in the
amygdala via activation of GRPR clearly modulates amygdala
physiology and some paradigm-specific forms of emotional
memory. However, these effects are not potent enough to
significantly attenuate strongly conditioned aversive learning
experiences making it unlikely that GRPR modulation would be
a broadly applicable therapeutic principle for amygdala-depen-
dent disorders.
Materials and Methods
Ethics Statement
All experiments were conducted in accordance with interna-
tional guidelines and the Swiss Law for the care and use of animals
and were approved by the Kantonales Veterina ¨ramt Basel-Stadt.
Animals
Male GRP receptor knock-out mice (backcrossed N.9
generations to the C57BL/6J strain, [46], were bred and raised
in the Novartis SPF-breeding facility. Genotyping was performed
by RT-PCR. C57BL/6J mice were purchased from Janvier
(France) or Charles River (Germany). One to 5 mice were housed
in each cage. Food (Provimi Kliba SA; Kaiseraugst, Switzerland)
and water were available ad libitum. Mice 2–3 months old were
used for all behavioral and electrophysiology experiments except
for the patch-clamp recordings, which were performed in brain
slices prepared from 4–6 week old mice.
Histology
In situ hybridization. 20 mm coronal sections were
prepared from fresh frozen mouse (10 to 12 week old male
C57BL/6) brains, fixed for 1 h in PBS buffered 4% para-
formaldehyde, dehydrated in increasing ethanol solutions and
subjected to an automated ISH procedure (VENTANA Discovery
XT technology). Briefly, sections were postfixed for 4 min with
VENTANA RiboPreb
TM solution and conditioned by heat
denaturation (12 min at 98uC in citrate buffer, pH 6.0) followed
by mild protease treatment (incubation with VENTANA protease
III for 4 min at 37uC). Sections were then hybridized for 6 h
at 65uC with 1 ng/ml digoxigenin-labeled antisense RNA
(corresponding to nucleotides 638–1092 of mouse cDNA),
diluted in hybridization solution containing one part VENTANA
RiboHybe
TM, and two parts 26SSC, followed by high
stringency washing with 26SSC at 75uC for 368 min, and
post-fixation for 8 min in VENTANA RiboFix
TM. To visualize
hybridization signals, sections were incubated for 28 min
with alkaline phosphatase labeled sheep anti-digoxygenin Fab
fragments (Roche Diagnostics) diluted 1:500 in VENTANA
discovery antibody diluent, and subjected for 9 h to an alkaline
phosphatase-catalized color reaction with NBT/BCIP (VENTANA
BlueMap kit).
Dual in situ/immunofluorescence labeling. For dual
in situ and immunofluorescence staining to visualize GAD67
expressing GABAergic interneurons, 4 mm coronal sections from
paraffin embedded GAD67-eGFP transgenic mouse brains
were subjected to an automated ISH procedure followed by
immunofluorescence staining of eGFP. Briefly, paraffin sections
were de-waxed, postfixed and conditioned by heat pre-treatment
and moderate proteolysis (VENTANA protease III for 8 min at
37uC). Hybridization, washing and digoxygenin immunostaining
was performed as described. For eGFP immunofluorescence
staining, sections were incubated for 2 h at room temperature
with a goat anti-eGFP antibody (Abcam; diluted 1:200) followed
by incubation for 1 h at room temperature with ALEXA 488
labeled donkey anti-goat IgG (INVITROGEN). Slides were
analyzed by dual brightfield and fluorescence microscopy
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AnalySIS software, Soft Imaging Systems).
In vivo electrophysiology. Mice were anaesthetized with
3.6 g/kg intraperitoneal urethane. The animals were fixed in a
stereotaxic holder and body temperature was maintained around
37.2uC with a heating pad. Animals received 1 ml of isotonic
saline solution intraperitoneally every hour. The skull was exposed
with one longitudinal midline cut and a hole for the recording
electrode was made 1 mm caudal to Bregma and 2.6 mm lateral
from the midline. To record CeA neuron activity, a glass electrode
filled with 2 M NaCl and 2.5% pontamine sky blue (tip broken to
about 3 mm) was introduced through the opening. In each animal,
4 recording electrode tracks were made in a parasagittal plane (0.8,
0.9, 1.0, and 1.1 mm caudal to Bregma, 2.6 mm lateral from the
midline). Recordings were made from all neurons encountered
between 3.8 and 4.5 mm below the cortical surface. Extracellular
single units were AC coupled and amplified with a Grass P16
amplifier and acquired using custom-written software running in
LabView (New Visions Engineering, Switzerland). Single units
were distinguished using a window discriminator and average
spontaneous firing frequency was calculated from 50 3 s sweeps
collected every 6 s. For histological verification of the recording
sites, pontamine sky blue was ejected from the recording pipette at
the last recording site. Brains were then processed for histology to
verify recording sites as described below.
In vitro electrophysiology. Mice were anaesthetized with
isoflurane and killed by decapitation. Brains were rapidly removed
and coronal slices (350–400 mM thick) containing the amygdaloid
complex were cut with a Leica VT vibratome or a Microm
vibratome in ice-cold saline equilibrated with 95%O2/5%CO2
containing (in mM): NaCl 124; KCl 2.5; KH2PO4 1.2; CaCl2 2.5;
MgSO4 1.3; NaHCO3 26, glucose 10, saccharose 4 (pH 7.4,
osmolarity adjusted to 32062 mOsm by reducing amount of
H2O). After cutting slices were maintained in the same solution
but fully diluted to give osmolarity 30662 mOsm at room
temperature.
For field recordings, slices were transferred to an interface-type
recording chamber and superfused with the above solution at
27uC. Stimulation and recording electrodes were positioned to
activate either cortical or thalamic inputs to the LA [47]. Stimuli
were delivered with a constant current stimulus isolation unit to
evoke a fEPSP that was 25–40% of the maximum. Responses
were recorded with an Axoprobe 1A amplifier and pClamp
9.0 software. Data were analyzed with custom written analysis
routines in VBA and Excel. After recording test responses at 30 s
intervals to obtain a 10 min baseline period, LTP was induced
with 561 s trains of 100 Hz stimuli at the test amplitude delivered
every 20 seconds. Data were normalized to the baseline fEPSP
slope and are expressed as mean 6 SEM.
For whole-cell patch clamp recordings slices were superfused in
a submersion chamber with ACSF containing: (in mM) 119 NaCl,
2.5 KCl, 2.5 CaCl2, 1.0 MgSO4, 1.25 NaH2PO4, 26.0 NaHCO3,
10 glucose, equilibrated with 95% O2/5% CO2 (pH 7.3–7.4) at
room temperature. Pyramidal shaped neurons were visually
identified and whole-cell recordings were established with pipettes
(3–5 MV) containing (in mM): 130 KCl, 5 NaCl, 1 MgCl2, 0.2
EGTA, 10 HEPES, 2 MgATP, and 0.1 NaGTP (adjusted to
pH 7.2 with KOH) to record IPSCs, or 120 mM K-gluconate, 15
KCl, 5 NaCl, 1 MgCl2, 0.2 EGTA, 10 HEPES, 2 MgATP, and
0.1 NaGTP (adjusted to pH 7.2 with KOH) to record evoked
EPSCs. Recordings were made using an Axopatch 200A amplifier
and analyzed using Clampfit and Excel. IPSCs were recorded at
270 mV in the presence of 20 mM CNQX and 50 mM APV to
block excitatory AMPA/kainate and NMDA receptor mediated
currents. EPSCs were recorded at 270 mV. Series resistance was
8–20 MV.
Fear conditioning
Apparatus and data collection. Experimentally naive mice
were handled daily by the experimenter for at least 6 days prior to
the beginning of the experiment.
Fear conditioning experiments were performed using an
automated fear-conditioning system (TSE, Bad Homburg, Ger-
many). The apparatus consists of 4 identical conditioning test
chambers (46 cm646 cm632 cm). Each test chamber is placed
inside frames equipped with animal detection sensors and is
located in a sound-attenuating box equipped with a loud speaker
(for delivering white noise and acoustic stimuli), light (10 W), a
ventilation fan in the side wall. The floor of the conditioning test
chambers consists of a removable stainless steel foot-shock grid
(bars: 4 mm diameter, distance from rod center to rod center:
8.9 mm) connected to a shock unit delivering shocks of defined
duration and intensity. Conditioned stimulus (CS) and uncondi-
tioned stimulus (US) delivery were controlled by a personal
computer using a program provided by TSE.
Movements of the mice were automatically registered by
infrared beams spaced every 1.4 cm. Freezing behavior (=immo-
bility) was defined as the absence of any beam crossings for more
than 1 s. For each study, freezing was automatically recorded
during fear acquisition (conditioning phase) and during each
subsequent session. All sessions were conducted under constant
white noise (60 dB) and dim illumination (8 lux). Conditioning
and testing for context-dependent freezing was performed in
transparent Perspex conditioning boxes (context 1) that were
cleaned with 70% ethanol between each conditioning or test
session, but testing for cue-induced fear and extinction training
were performed in opaque black Perspex boxes (context 2), with 2
black crosses and a black rectangle on the ceiling, that were
cleaned with 1% acetic acid between each test session.
Single-trial fear conditioning. On day 1 the animals were
individually placed into the transparent Perspex conditioning
boxes (context 1) for 2 min of habituation during which time
baseline freezing was recorded. Then the trial was started and 30 s
later a single conditioned stimulus (CS, tone 2.8 kHz, 85 dB, 30 s)
was presented that co-terminated with the unconditioned stimulus
(US, 0.7 mA, 2 s, pulsed shock delivered through the grid floor,
CS and US parameters from [18]). Sixty seconds after the shock
the mice were returned to their home cage.
On day 2 (24 h after the conditioning), animals were tested for
contextual freezing (for 3 min) in context 1. The animals were
returned to their own home cage for 3 h. Then, to evaluate the
cue-induced freezing, the animals were placed in the black boxes
(context 2) and after 1 min (pre-CS) were presented with the tone
(CS: 2.8 kHz, 85 dB, 120 s). The retention tests for context and
cue were repeated 2 weeks after conditioning.
Multiple-trial fear conditioning and fear extinction. Fear
conditioning proceeded as above in context 1 except that on day 1
the conditioning consisted of 6 pairings of the CS (tone 10 kHz,
85 dB, 30 s) co-terminating with the US (0.6 mA, 2 s, pulsed
shock delivered through the grid floor) at 60 s inter-trial intervals
(ITI) in context 1. Mice were returned to their home cage 60 s
after the last tone/shock event.
Extinction training started 24 h after conditioning (day 2), and
consisted of the presentation of 10 CS (ITI 60 s) in context 2 as
above. Extinction training was then repeated in context 2 on days
3 and 4 (in total: 3610 CS presentations). On day 2, the freezing
response induced by the first 5 CS was considered as the freezing
level before extinction (=expression of cue-induced freezing,
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(wild-type and knock-out) did not receive extinction training (non-
extinguished animals). These animals were returned to their home
cages after 5 CS presentations on day 2 and were placed in context
2 on days 3 and 4 for 10 min without any CS or US presentation.
On day 5, mice from all groups were placed in context 2 and
submitted to a final retention test consisting of 10 CS presented in
the absence of shock (all mice were tested).
Intra-amygdala injections
Mice were anesthetized with ketamine/xylazine (100 mg/kg
ketamine and 10 mg/kg xylazine, i.p.) and placed in a stereotaxic
frame. The skull was exposed and stainless steel guide cannulae
(diameter: 0.35 mm; length: 6 mm) were bilaterally implanted in
the amygdala. using the following coordinates [48]: 1.5 mm
caudal from Bregma, 63.5 mm lateral from Bregma, 23.7 mm
ventral from the dura. The guide cannulae were fixed to the skull
with acrylic cement and 2–3 anchoring screws. The behavioral
tests started following full recovery (5–6 days) of the animals from
surgery. To prevent post-surgery pain, the analgesic Buprenorphin
(0.01 mg/kg, i.p.) was given twice a day on the first 2 days
following surgery.
On day 2 after multiple-trial fear conditioning (see below),
600 ng GRP (0.21 nmol), 3000 ng of the GRPR antagonist (D-
Phe
6,Leu-NHEt
13,des-Met
14)-Bombesin(6–14) (3.05 nmol) or ve-
hicle (saline) was injected into the amygdala in awake mice 15 min
before the retention test. The solutions were administered in a
total volume of 0.3 ml through stainless steel cannulae injectors
(diameter: 0.15 mm). Injectors were connected to a Hamilton
syringe via polyethylene tubes and a microinfusion pump
(CMA100, CMA, Stockholm, Sweden). The solution was slowly
injected over 3 min and the injector was left in place for an
additional 60 s before removal. After the infusions, mice were
returned to their home cages for 10 min before starting the
retention test.
Verification of injection sites. After behavioral testing, the
animals were euthanized and 0.3 ml methylene blue was injected
to mark the injection site. Brains were removed and immersion-
fixed in 4% paraformaldehyde. Prior to cutting, the brains were
transferred to phosphate buffered 30% sucrose for at least 12 h.
Frontal sections (100 mm) were cut on a freezing microtome.
Sections were mounted on gelatinized slides, counterstained with
cresyl violet, dehydrated and coverslipped. The injection sites were
localized and the extent of tissue lesions were examined under a
light microscope. The injection sites were drawn on plates taken
from a mouse brain atlas [48]. Data from animals where the
injection sites were misplaced or that showed large tissue lesions
were excluded from the analysis.
Conditioned taste aversion
Mice were housed singly throughout the experiment and were
pre-trained for 3 days to obtain water from a drinking tube that
was present in the home cage during two 30 min periods per day.
Drinking tubes were made by cutting off the tip of 15 ml FalconH
tubes to make an opening of 2–3 mm diameter. One drinking
period was in the morning and one in the afternoon. Following the
training period experiments were performed during the morning
drinking session and only water was given in the afternoon
sessions. The tubes were weighed to determine consumption. Food
pellets were available ad libitum.
In the conditioning trial, in the morning drinking session only
0.5% saccharin solution was offered in a single tube as the stimulus
designed to become the conditioned stimulus (CS). To establish a
conditioned taste aversion (CTA), WT or GRPR KO mice were
injected with the US, LiCl, freshly dissolved in saline (6 mEq/kg in
a volume of 10 ml/kg i.p.) 30 min after the end of the saccharin
drinking session. Control WT and GRPR KO mice were given
saccharin to drink and injected with NaCl solution (NaCl group)
or given only water to drink and injected with NaCl (saccharin-
naive group).
Memory retrieval preference tests took place in the morning
session 24 h after conditioning (Day 1). During the 30 min
morning session, all animals were offered 2 tubes simultaneously:
one filled with tap water, the other with 0.5% saccharin solution.
The aversion index (AI) was calculated as follows:
AI~10|water intake ml ðÞ =
water intake ml ðÞ zsaccharin intake ml ðÞ ½Þ
and ranged from 0 (for 100% saccharin preference) to 100 (for
100% water preference). Retrieval tests on subsequent days
determined the amount of extinction of CTA.
Attenuation of gustatory neophobia
Neophobia was determined from the difference in AI upon first
exposure to a novel taste (saccharin naive) and the AI of mice that
previously drank saccharin (NaCl group). The same mice used as
the control groups in the CTA were assessed in this test.
Attenuation of neophobia was assessed by comparing the decrease
in AI seen during subsequent testing days.
Statistical analyses
Data are presented as mean 6 SEM. Statistical analyses were
performed with SYSTAT (version 10 or 11 SPSS Inc.). A two-
factor analysis of variance (ANOVA) with genotype and trial type
as factors was used for the conditioning phase of the fear
conditioning experiments after verifying that the data were
normally distributed. Retention was analysed with genotype and
time or cue as factors. When differences were found paired t-tests
with Bonferroni corrections (24 h, 2 weeks) or Student’s t-tests
were applied. Extinction was compared by two-way ANOVA with
genotype and extinction procedure as factors. For the pharmaco-
logical experiments, two-factor analysis of variance (ANOVA) with
trial type (cue or minute) and drug treatment as factors was
performed.
The conditioned taste aversion and attenuation of neophobia
data were also analysed by two-factor ANOVA. If there was a
significant effect of treatment or a significant group6day
interaction (after Huynh-Feldt and Greenhouse-Geisser correc-
tion), individual groups were compared to the control group by
means of Dunnett’s multiple comparison test (two-tailed).
For the electrophysiological experiments paired t-tests were used
to compare IPSC frequency before and after application of GRP.
Student’s t-tests were used to compare differences in LTP between
WT and GRPR KO mice.
Chemicals
Salts used to prepare solutions were from Fluka or Merck
(Switzerland). GRP and the GRPR antagonist (D-Phe
6, Leu-
NHEt
13, des-Met
14)-Bombesin (6–14) were from Bachem AG
(Switzerland). Picrotoxin was from Sigma (Switzerland). CNQX,
NBQX and APV were from Tocris-Cookson (UK).
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